NCT01421407View on ClinicalTrials.gov

Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Secondary HyperparathyroidismEnd Stage Renal DiseaseParathyroid Hyperplasia
Interventions
DEVICE

Ultrasonic ablation device

High Intensity Focused Ultrasound treatment

Trial Locations (3)

20122

Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan

39008

Hospital Universitario Marquès de Valdecilla, Santander

70021

"Ospedale generale regionale Miulli", Acquaviva delle Fonti

Sponsors

Lead Sponsor

Theraclion
All Listed Sponsors
lead

Theraclion

INDUSTRY

NCT01421407 - Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism | Biotech Hunter | Biotech Hunter